Literature DB >> 1744125

Purification of the transforming growth factor-beta (TGF-beta) binding proteoglycan betaglycan.

J L Andres1, L Rönnstrand, S Cheifetz, J Massagué.   

Abstract

We report the purification of betaglycan, a low-abundance membrane proteoglycan with high affinity for transforming growth factor-beta (TGF-beta). Betaglycan solubilized from rat embryo membrane preparations was purified to near-homogeneity by sequential chromatography through DEAE-Trisacryl, wheat germ lectin-Sepharose, and TGF-beta 1-agarose. Purified betaglycan has properties similar to betaglycan affinity-labeled in intact cells: it binds TGF-beta 1 and TGF-beta 2 with KD approximately 0.2 nM, contains heparan sulfate and chondroitin sulfate glycosaminoglycan (GAG) chains and N-linked glycans attached to a 110-kDa core protein, and can spontaneously associate with phosphatidylcholine liposomes. The betaglycan core obtained by enzymatic removal of the GAG chains has high affinity for TGF-beta and associates with artificial liposomes, indicating that the core protein binds TGF-beta and anchors to membranes independently of the GAG chains present on the native protein or of any ancillary protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1744125

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion.

Authors:  Karthikeyan Mythreye; Gerard C Blobe
Journal:  Cell Signal       Date:  2009-05-08       Impact factor: 4.315

2.  A modifier locus on chromosome 5 contributes to L1 cell adhesion molecule X-linked hydrocephalus in mice.

Authors:  Alexis Tapanes-Castillo; Eli J Weaver; Robin P Smith; Yoshimasa Kamei; Tamara Caspary; Kara L Hamilton-Nelson; Susan H Slifer; Eden R Martin; John L Bixby; Vance P Lemmon
Journal:  Neurogenetics       Date:  2009-06-30       Impact factor: 2.660

3.  Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.

Authors:  Li-Yuan Yu-Lee; Guoyu Yu; Yu-Chen Lee; Song-Chang Lin; Jing Pan; Tianhong Pan; Kai-Jie Yu; Bin Liu; Chad J Creighton; Jaime Rodriguez-Canales; Pamela A Villalobos; Ignacio I Wistuba; Eulalia de Nadal; Francesc Posas; Gary E Gallick; Sue-Hwa Lin
Journal:  Cancer Res       Date:  2018-03-07       Impact factor: 12.701

4.  Functional overlap between chondroitin and heparan sulfate proteoglycans during VEGF-induced sprouting angiogenesis.

Authors:  Sébastien Le Jan; Makoto Hayashi; Zsolt Kasza; Inger Eriksson; Joseph R Bishop; Irene Weibrecht; Johan Heldin; Katarina Holmborn; Lars Jakobsson; Ola Söderberg; Dorothe Spillmann; Jeffrey D Esko; Lena Claesson-Welsh; Lena Kjellén; Johan Kreuger
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-16       Impact factor: 8.311

5.  Expression of cell-surface proteoglycan mRNA by human articular chondrocytes.

Authors:  J Grover; P J Roughley
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

Review 6.  Cytokines and proteoglycans.

Authors:  J J Nietfeld
Journal:  Experientia       Date:  1993-05-15

Review 7.  Cathepsin B and other proteases in human colorectal carcinoma.

Authors:  J M Jessup
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

8.  Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent.

Authors:  M M Vilchis-Landeros; J L Montiel; V Mendoza; G Mendoza-Hernández; F López-Casillas
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

Review 9.  Iduronic acid in chondroitin/dermatan sulfate: biosynthesis and biological function.

Authors:  Anders Malmström; Barbara Bartolini; Martin A Thelin; Benny Pacheco; Marco Maccarana
Journal:  J Histochem Cytochem       Date:  2012-08-16       Impact factor: 2.479

Review 10.  Biology of human colon cancer metastasis.

Authors:  M Gutman; I J Fidler
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.